Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative)

v3.10.0.1
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]
Jan. 04, 2019
USD ($)
$ / shares
shares
Aspire Capital [Member]  
Subsequent Event [Line Items]  
Number of shares issued | shares 815,429
Shares issued price per share (in dollars per share) | $ / shares $ 1.40
Proceeds from issuance of stock $ 1,100,000
Agreement And Plan Of Merger [Member]  
Subsequent Event [Line Items]  
Percentage of securityholders collectively own on a fully diluted basis 5.90%
Termination right term Upon certain terminations of the Merger Agreement, MYnd may be required to pay Emmaus a termination fee of $750,000 and Emmaus may be required to pay MYnd a termination fee of $750,000; provided that if the termination results from the failure to obtain the approval of the continued listing of the combined company’s common stock on the NasdaqCM, this fee payable by Emmaus will be $1,600,000.
Third party expenses pay to other party $ 600,000
Agreement And Plan Of Merger [Member] | Emmaus Life Sciences, Inc. [Member]  
Subsequent Event [Line Items]  
Percentage of securityholders collectively own on a fully diluted basis 94.10%
Percentage of share issued with debt conversion 5.90%